176 related articles for article (PubMed ID: 16899063)
1. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
3. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
[TBL] [Abstract][Full Text] [Related]
4. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
Jonsson KO; Andersson A; Jacobsson SO; Vandevoorde S; Lambert DM; Fowler CJ
Arch Toxicol; 2003 Apr; 77(4):201-7. PubMed ID: 12698235
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
7. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
8. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
9. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
10. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Cabranes A; Pryce G; Baker D; López-Rodríguez M; Ramos JA
Eur Neuropsychopharmacol; 2006 Jan; 16(1):7-18. PubMed ID: 16006105
[TBL] [Abstract][Full Text] [Related]
11. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
Trezza V; Vanderschuren LJ
J Pharmacol Exp Ther; 2009 Jan; 328(1):343-50. PubMed ID: 18948500
[TBL] [Abstract][Full Text] [Related]
13. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
Bradshaw HB; Rimmerman N; Hu SS; Benton VM; Stuart JM; Masuda K; Cravatt BF; O'Dell DK; Walker JM
BMC Biochem; 2009 May; 10():14. PubMed ID: 19460156
[TBL] [Abstract][Full Text] [Related]
16. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
18. Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6 glioma cells assessed by the MTT cell viability assay: implications for the methodology of the MTT tests.
Bilmin K; Kopczyńska B; Grieb P
Folia Neuropathol; 2013; 51(1):44-50. PubMed ID: 23553136
[TBL] [Abstract][Full Text] [Related]
19. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.
Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V
Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.
Jacobsson SO; Wallin T; Fowler CJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):951-9. PubMed ID: 11714882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]